A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity.

Hiroshi FujiwaraMasashi KubotaYu HidakaKaoru ItoTakashi KawaharaRyoma KurahashiYuto HattoriYusuke ShiraishiYusuke HamaNoriyuki MakitaYu TashiroShotaro HatanoRyosuke IkeuchiMasakazu NakashimaNoriaki UtsunomiyaYasushi TakashimaShinya SomiyaKanji NagahamaTakeru FujimotoKosuke ShimizuKazuto ImaiTakehiro TakahashiTakayuki SumiyoshiTakayuki GotoSatoshi MoritaTakashi KobayashiShusuke Akamatsu

Published in: International journal of clinical oncology (2024)

The novel model based on prognostic factors can predict patient outcomes with high accuracy and reproducibility. The model may be used to optimize the treatment intensity of de novo mHSPC.

Keyphrases

prostate cancer
prognostic factors
squamous cell carcinoma
small cell lung cancer
high intensity
radical prostatectomy
replacement therapy